Advertisement

Topics

Mewburn Ellis Company Profile

09:48 EST 16th December 2018 | BioPortfolio

Mewburn Ellis was originally founded around 1890 and became Mewburn Ellis LLP in 2004. We have offices in central London, Bristol, Manchester and Cambridge.
Day to day handling of European and UK intellectual property rights inevitably brings us special expertise in European/UK intellectual property practice. We believe strongly that our role is to provide a positive service giving the benefit of that expertise to every client, whether British or from overseas.
Our first aim is therefore always to be responsive and alert to the instructions and information which our client provides. We do not carry out instructions passively, but seek positively to make additional contributions using our special expertise. This distinctive approach often leads to beneficial changes in a proposed course of action, and has particular value for overseas associates.
We aim also to treat our clients' intellectual property rights not in isolation, but as part of their legal, commercial and industrial environment, for example in licensing and other technology transfer contexts.
The last two decades have brought major changes in intellectual property law and practice around the world, and notably in Europe. Over that period Mewburn Ellis has grown considerably, keeping pace with the consequent increase in the quantity and diversity of international work.

Location

York House23 Kingsway
London
London
WC2B 6HP
United Kingdom

Contact

Phone: 44 20 7240 4405
Fax: 44 20 7240 9339
Email: mail@mewburn.com


News Articles [28 Associated News Articles listed on BioPortfolio]

New Partners at Mewburn Ellis LLP

The Partners of Mewburn Ellis LLP are pleased to announce that with effect from 1 April 2014 Katherine Green and Sean Jauss will join the partnership. This brings the number of Partners in the firm to...

Mewburn Ellis LLP congratulates long-term client, Spirogen, on their acquisition by AstraZeneca’s MedImmune

Mewburn Ellis LLP are delighted that the acquisition of Spirogen by MedImmune from Auven Therapeutics for $200 million has been successfully concluded. The deal also involved a deferred consideration...

Marrs Ellis Hodge Partner Luke Ellis Named to 2019 "Best Lawyers in ...

AUSTIN, Texas, Aug. 27, 2018 /PRNewswire/ -- Luke Ellis, founding partner of the Texas-based litigation boutique Marrs Ellis & Hodge LLP, has been selected for Read more...

Congratulations to Genentech on receiving The Economist ‘Corporate use of Innovation Award’

Mewburn Ellis LLP congratulates long-term client Genentech on being awarded The Economist ‘Corporate use of Innovation Award 2013’. Genentech are recognised as a pioneer of the biotechnolo...

Dr. Neil Ellis Joins Physician Partners of America in Tampa

TAMPA, Fla. (PRWEB) November 29, 2018 Physician Partners of America welcomes Neil Ellis , M.D., M.T.C.M, to its Tampa practice at 4...

Donald Henry Ellis

bmj;363/dec03_3/k5049/FAF1faDonald Henry Ellis (“Don”) was born and brought up in Birmingham’s deprived Bordesley Green ward, where he also practised as a highly committed and inspiring GP from ...

Sophie Louise Ellis

bmj;361/jun15_3/k2651/FAF1faAfter house jobs in London, Sophie Louise Ellis (née Bassindale) joined the Oxford general practitioner scheme. She moved to Milton Keynes and worked in primary care roles...

Ellis Examines CDK4/6 Inhibitor Use in HR+ Breast Cancer

Matthew J. Ellis, MD, PhD, discusses the use of CDK4/6 inhibitors in the treatment of patients with hormone receptor–positive breast cancer.

Drugs and Medications [0 Results]

None

PubMed Articles [10 Associated PubMed Articles listed on BioPortfolio]

Chondroectodermal Syndrome.

Chondroectodermal syndrome or Ellis Van Creveld (EVC) is a rare autosomal recessive congenital disorder. It was first described by Richard W.B.Ellis and Simon Van Creveld in 1940. Parental consanguini...

Dr. elliot f. ellis: initiating personalized asthma management in children.

Elliot F. Ellis is indeed a giant in the field of allergy and immunology. From his leadership role in developing a pediatric allergy and immunology fellowship at National Jewish Health and his seminal...

A novel strategy for evaluation of natural products acting on the myeloperoxidase/hypochlorous acid system by combining high-performance liquid chromatography-photodiode array detection-chemiluminescence and ultrafiltration-mass spectrometry techniques.

Myeloperoxidase and its product hypochlorous acid are endogenous substances that are involved in the pathogenesis of many inflammatory diseases. In the present study, a novel evaluation strategy has b...

Novel approach to coronary artery perforation repair.

Coronary artery perforation (CAP) during percutaneous coronary intervention is a rare but serious complication. Treatment options of CAP include prolonged balloon inflation, covered stent, and coil em...

Toward a nuanced understanding of nondisclosure in psychotherapy supervision.

Previous research indicates that trainees often withhold important information related to their clients' progress and their reactions to supervision. Moreover, factors associated with the occurrence o...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Upside Down, Give me the Handle

In schizophrenia, dislocation of psychic functions involving a loss of contact with reality is frequently found. A fragmentation of motor and sensory perceptions could be held responsible ...

Have a Good Grasp of the Worldthe World

Brief Summary: In schizophrenia, dislocation of psychic functions involving a loss of contact with reality is frequently found. A fragmentation of motor and sensory perceptions could be he...

Investigating the Acute and Chronic Effects of an American Ginseng Root Extract on Cognition and Mood

Ginseng refers to the extract of any slow growing perennial plant with a fleshy root, deriving from the Panax genus of the Araliaceae family. Ginseng root has been used as an intervention ...

Study of Skeletal Disorders and Short Stature

This study will determine the genes responsible for skeletal dysplasias (disorders of the skeleton) and short stature and define the range and type of medical problems they cause over time...

Companies [17 Associated Companies listed on BioPortfolio]

Mewburn Ellis

Mewburn Ellis was originally founded around 1890 and became Mewburn Ellis LLP in 2004. We have offices in central London, Bristol, Manchester and Cambridge.Day to day handling of European and UK intel...

Grubb & Ellis Company

Since its founding in 1958, Grubb & Ellis has prided itself on its dedication to client service. From its beginnings as a single office in Northern California, that dedication has allowed Grubb & Elli...

Grubb & Ellis Equity Advisors, LLC

Grubb & Ellis Equity Advisors, LLC is the primary investment and asset management subsidiary of Grubb & Ellis Company (NYSE: GBE), one of the largest and most respected commercial real estate services...

Ellis & Watts Global Industries

Founded in 1952, Ellis & Watts Global Industries specializes in engineering and manufacturing HVAC, mobile, heat transfer, and barrier systems for healthcare, military, nuc...

Grubb & Ellis Healthcare REIT II, Inc.

Grubb & Ellis Healthcare REIT II, Inc. intends to qualify as a real estate investment trust that seeks to preserve, protect and return investors' capital contributions, pay regular cash distributions,...

More Information about "Mewburn Ellis" on BioPortfolio

We have published hundreds of Mewburn Ellis news stories on BioPortfolio along with dozens of Mewburn Ellis Clinical Trials and PubMed Articles about Mewburn Ellis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mewburn Ellis Companies in our database. You can also find out about relevant Mewburn Ellis Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record